Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Albrecht

Showing results (241-250 of 245) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 245 results.
Gastroenterology|April 20, 2010
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virusAlexander J Thompson, Andrew J Muir, Mark S Sulkowski, et al.
The Journal of Biological Chemistry|April 9, 2016
Regulatory T Cell Modulation by CBP/EP300 Bromodomain InhibitionSrimoyee Ghosh, Alexander Taylor, Melissa Chin, et al.
Journal of Medicinal Chemistry|September 12, 2017
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)F Anthony Romero, Jeremy Murray, Kwong Wah Lai, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)Alexander M Taylor, Alexandre Côté, Michael C Hewitt, et al.
Journal of Medicinal Chemistry|September 30, 2016
Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300Terry D Crawford, F Anthony Romero, Kwong Wah Lai, et al.
Pageof 25

Showing results (241-250 of 245) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 245 results.
Gastroenterology|April 20, 2010
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virusAlexander J Thompson, Andrew J Muir, Mark S Sulkowski, et al.
The Journal of Biological Chemistry|April 9, 2016
Regulatory T Cell Modulation by CBP/EP300 Bromodomain InhibitionSrimoyee Ghosh, Alexander Taylor, Melissa Chin, et al.
Journal of Medicinal Chemistry|September 12, 2017
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)F Anthony Romero, Jeremy Murray, Kwong Wah Lai, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)Alexander M Taylor, Alexandre Côté, Michael C Hewitt, et al.
Journal of Medicinal Chemistry|September 30, 2016
Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300Terry D Crawford, F Anthony Romero, Kwong Wah Lai, et al.
Pageof 25